Market Place
Sourcing Support
Statement from Arranta Bio on settlement of Thermo Fisher litigation
05 Jun 2023 //
PRESS RELEASE
Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics
28 Apr 2023 //
PRESS RELEASE
Recipharm`s Arranta Bio expands RNA process development capacity
09 Mar 2023 //
PRESS RELEASE
Recipharm completes US biologics acquisitions
11 Apr 2022 //
PRESS RELEASE
Swedish CDMO Recipharm is absording Arranta Bio and Vibalogics
19 Feb 2022 //
FIERCEPHARMA
Arranta Bio Completes Sale of Florida Site to Inceptor Bio
16 Nov 2021 //
CONTRACTPHARMA
Arranta Bio: Completion of Sale of Florida Site & $150M Investment Plan
15 Nov 2021 //
PRNEWSWIRE
Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility
27 Oct 2021 //
BIOSPACE
Arranta Bio Unveils mRNA Vaccines Manufacturing Capability
23 Sep 2021 //
CONTRACTPHARMA
Arranta Bio Invests in New Manufacturing Facility
09 Mar 2021 //
CONTRACTPHARMA
CDMO Arranta Bio splashes $100M into `microbiome` manufacturing
29 Sep 2020 //
FIERCE PHARMA
Arranta Bio Announces Addition of Shailesh Maingi to its Board Director
09 Jun 2020 //
PRNEWSWIRE
Arranta Bio Expands Microbiome Capacity at CoE
28 May 2020 //
PRNEWSWIRE
BioMarin breaks out +ve PhII achondroplasia data; Thermo Fisher opens
14 Nov 2019 //
ENDPTS
Arranta Bio Acquires Captozyme
13 Nov 2019 //
CONTRACT PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.